ELMA SAHBAZ: Open Payments
NPI 1184499774 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$287 in 7 payments from 3 companies in 2025. Trend: 2023 $140 · 2024 $249 · 2025 $287
Food & beverage: $287
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $132 |
| Teva Pharmaceuticals USA, Inc. | 2 | $93 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
Products named: INGREZZA, AUSTEDO XR, REXULTI, UZEDY.
Industry payments across MO — which companies pay providers there.
